Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination intravenous formulation containing lactated Ringer's solution and oxytocin. Lactated Ringer's solution is an isotonic crystalloid fluid composed of sodium chloride, sodium lactate, potassium chloride, and calcium chloride in water. It is used for fluid and electrolyte replenishment in patients with low blood volume or low blood pressure, as well as to treat dehydration, metabolic acidosis, or to facilitate the delivery of IV medications[1][3][5]. Oxytocin is a peptide hormone that stimulates uterine contractions by acting on oxytocin receptors in the uterine smooth muscle; it is commonly used to induce labor or control postpartum bleeding. The combination may be used in obstetric settings where both volume resuscitation and induction/augmentation of labor are required.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lactated ringers + oxytocin.